Cargando…

Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions

Primary lung carcinoma or lung cancer (LC) is classified into small-cell or non-small-cell (NSCLC) lung carcinoma. Lung squamous cell carcinoma (LSCC) is the second most common subtype of NSCLC responsible for 30% of all LCs, and its survival remains low with only 24% of patients living for five yea...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahu, Priyanka, Donovan, Chantal, Paudel, Keshav Raj, Pickles, Sophie, Chimankar, Vrushali, Kim, Richard Y., Horvart, Jay C., Dua, Kamal, Ieni, Antonio, Nucera, Francesco, Bielefeldt-Ohmann, Helle, Mazilli, Sarah, Caramori, Gaetano, Lyons, J. Guy, Hansbro, Philip M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560855/
https://www.ncbi.nlm.nih.gov/pubmed/37817767
http://dx.doi.org/10.3389/fonc.2023.1260411
_version_ 1785117812939816960
author Sahu, Priyanka
Donovan, Chantal
Paudel, Keshav Raj
Pickles, Sophie
Chimankar, Vrushali
Kim, Richard Y.
Horvart, Jay C.
Dua, Kamal
Ieni, Antonio
Nucera, Francesco
Bielefeldt-Ohmann, Helle
Mazilli, Sarah
Caramori, Gaetano
Lyons, J. Guy
Hansbro, Philip M.
author_facet Sahu, Priyanka
Donovan, Chantal
Paudel, Keshav Raj
Pickles, Sophie
Chimankar, Vrushali
Kim, Richard Y.
Horvart, Jay C.
Dua, Kamal
Ieni, Antonio
Nucera, Francesco
Bielefeldt-Ohmann, Helle
Mazilli, Sarah
Caramori, Gaetano
Lyons, J. Guy
Hansbro, Philip M.
author_sort Sahu, Priyanka
collection PubMed
description Primary lung carcinoma or lung cancer (LC) is classified into small-cell or non-small-cell (NSCLC) lung carcinoma. Lung squamous cell carcinoma (LSCC) is the second most common subtype of NSCLC responsible for 30% of all LCs, and its survival remains low with only 24% of patients living for five years or longer post-diagnosis primarily due to the advanced stage of tumors at the time of diagnosis. The pathogenesis of LSCC is still poorly understood and has hampered the development of effective diagnostics and therapies. This review highlights the known risk factors, genetic and epigenetic alterations, miRNA biomarkers linked to the development and diagnosis of LSCC and the lack of therapeutic strategies to target specifically LSCC. We will also discuss existing animal models of LSCC including carcinogen induced, transgenic and xenograft mouse models, and their advantages and limitations along with the chemopreventive studies and molecular studies conducted using them. The importance of developing new and improved mouse models will also be discussed that will provide further insights into the initiation and progression of LSCC, and enable the identification of new biomarkers and therapeutic targets.
format Online
Article
Text
id pubmed-10560855
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105608552023-10-10 Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions Sahu, Priyanka Donovan, Chantal Paudel, Keshav Raj Pickles, Sophie Chimankar, Vrushali Kim, Richard Y. Horvart, Jay C. Dua, Kamal Ieni, Antonio Nucera, Francesco Bielefeldt-Ohmann, Helle Mazilli, Sarah Caramori, Gaetano Lyons, J. Guy Hansbro, Philip M. Front Oncol Oncology Primary lung carcinoma or lung cancer (LC) is classified into small-cell or non-small-cell (NSCLC) lung carcinoma. Lung squamous cell carcinoma (LSCC) is the second most common subtype of NSCLC responsible for 30% of all LCs, and its survival remains low with only 24% of patients living for five years or longer post-diagnosis primarily due to the advanced stage of tumors at the time of diagnosis. The pathogenesis of LSCC is still poorly understood and has hampered the development of effective diagnostics and therapies. This review highlights the known risk factors, genetic and epigenetic alterations, miRNA biomarkers linked to the development and diagnosis of LSCC and the lack of therapeutic strategies to target specifically LSCC. We will also discuss existing animal models of LSCC including carcinogen induced, transgenic and xenograft mouse models, and their advantages and limitations along with the chemopreventive studies and molecular studies conducted using them. The importance of developing new and improved mouse models will also be discussed that will provide further insights into the initiation and progression of LSCC, and enable the identification of new biomarkers and therapeutic targets. Frontiers Media S.A. 2023-09-25 /pmc/articles/PMC10560855/ /pubmed/37817767 http://dx.doi.org/10.3389/fonc.2023.1260411 Text en Copyright © 2023 Sahu, Donovan, Paudel, Pickles, Chimankar, Kim, Horvart, Dua, Ieni, Nucera, Bielefeldt-Ohmann, Mazilli, Caramori, Lyons and Hansbro https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Sahu, Priyanka
Donovan, Chantal
Paudel, Keshav Raj
Pickles, Sophie
Chimankar, Vrushali
Kim, Richard Y.
Horvart, Jay C.
Dua, Kamal
Ieni, Antonio
Nucera, Francesco
Bielefeldt-Ohmann, Helle
Mazilli, Sarah
Caramori, Gaetano
Lyons, J. Guy
Hansbro, Philip M.
Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions
title Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions
title_full Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions
title_fullStr Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions
title_full_unstemmed Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions
title_short Pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions
title_sort pre-clinical lung squamous cell carcinoma mouse models to identify novel biomarkers and therapeutic interventions
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10560855/
https://www.ncbi.nlm.nih.gov/pubmed/37817767
http://dx.doi.org/10.3389/fonc.2023.1260411
work_keys_str_mv AT sahupriyanka preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT donovanchantal preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT paudelkeshavraj preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT picklessophie preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT chimankarvrushali preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT kimrichardy preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT horvartjayc preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT duakamal preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT ieniantonio preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT nucerafrancesco preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT bielefeldtohmannhelle preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT mazillisarah preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT caramorigaetano preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT lyonsjguy preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions
AT hansbrophilipm preclinicallungsquamouscellcarcinomamousemodelstoidentifynovelbiomarkersandtherapeuticinterventions